T1	Participants 67 96	patients with type 2 diabetes
T2	Participants 602 695	50 patients (serum creatinine, 1.5-3.9 mg/dL) with high-normal body lead burden (≥80-<600 μg)
T3	Participants 1396 1433	Chinese patients with type 2 diabetes
T4	Participants 2205 2229	type 2 diabetic patients